Abstract:The present study assessed the role of the p53 tumor suppressor gene in cell cycle arrest and apoptosis following treatment of Burkitt's lymphoma and lymphoblastoid cell lines with gamma-rays, etoposide, nitrogen mustard, and cisplatin. Cell cycle arrest was measured by flow cytometry; p53 and p21Waf1/Cip1 protein levels were measured by Western blotting; cell survival was measured in 72-96-h growth inhibition assays and by trypan blue staining, and apoptotic DNA fragmentation was assessed by either agarose gel electrophoresis or a modified filter elution method. We found that gamma-rays and etoposide induced a strong G1 arrest in the wild-type p53 lines while nitrogen mustard and cisplatin induced relatively little G1 arrest. All agents failed to induce G1 arrest in cells containing mutant p53 genes. The degree of G1 arrest observed with these agents correlated with the rate of p53 and p21Waf1/Cip1 protein accumulation: gamma-rays and etoposide induced rapid accumulation of both p53 and p21Waf1/Cip1; nitrogen mustard and cisplatin induced slow accumulation of p53 and no major accumulation of the p21Waf1/Cip1 protein. Despite differences in G1 arrest and kinetics of p53 or p21Waf1/Cip1 protein accumulation, all agents tended to decrease survival to a greater extent in the wild-type p53 lines compared to the mutant p53 lines. Cell death in the wild-type p53 lines was associated with intracellular DNA degradation into oligonucleosomal sized DNA fragments, indicative of apoptosis. We also observed an inverse sensitivity relationship between nitrogen mustard/cisplatin and etoposide in the mutant p53 lines and this was found to correlate with topoisomerase II mRNA levels in the cells. Our results suggest that p53 gene status is an important determinant of both radio- and chemosensitivity in lymphoid cell lines and that p53 mutations are often associated with decreased sensitivity to DNA damaging agents.

p53 Regulates Nuclear Architecture to Reduce Carcinogen Sensitivity and Mutagenic Potential

Δ113p53/Δ133p53 Converts P53 from a Repressor to a Promoter of DNA Double-Stand Break Repair.

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

p53 dynamics vary between tissues and are linked with radiation sensitivity

DNA repair processes are critical mediators of p53-dependent tumor suppression

An EZH2-mediated Epigenetic Mechanism Behind P53-Dependent Tissue Sensitivity to DNA Damage.

Suppression of Mismatched Mutation by P53: A Mechanism for Guarding Genomic Integrity

P53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms

Novel Role Of P53 In Maintaining Mitochondrial Genetic Stability Through Interaction With Dna Pol Gamma

p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage

p53 isoform |[Delta]|113p53/|[Delta]|133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage

Putting p53 in Context

p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice

At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity

The Nuclear Function of P53 is Required for Puma-Mediated Apoptosis Induced by Dna Damage

Radiation-induced Genetic Instability in Vivo Depends on P53 Status

Nucleophosmin Sets A Threshold for P53 Response to Uv Radiation

Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?

P53 Gene Mutations Are Associated with Decreased Sensitivity of Human Lymphoma Cells to DNA Damaging Agents.

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents.